Tribenzagan en es it fr

Tribenzagan Brand names, Tribenzagan Analogs

Tribenzagan Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Tribenzagan Chemical_Formula


Tribenzagan RX_link

No information avaliable

Tribenzagan fda sheet

Tribenzagan msds (material safety sheet)

Tribenzagan MSDS

Tribenzagan Synthesis Reference

No information avaliable

Tribenzagan Molecular Weight

280.285 g/mol

Tribenzagan Melting Point

No information avaliable

Tribenzagan H2O Solubility

No information avaliable

Tribenzagan State


Tribenzagan LogP


Tribenzagan Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Tribenzagan Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Tribenzagan Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Tribenzagan Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Tribenzagan side effects and Toxicity

No information avaliable

Tribenzagan Patient Information

No information avaliable

Tribenzagan Organisms Affected

Humans and other mammals